Assessing hospital reimbursement dynamics for a post-operative pain medication
Client sought to understand reimbursement dynamics that might influence uptake for a post-operative pain medication (e.g. quality metrics, guidelines).
Assessed relative near-term impact of a host of factors including IDN formulary, Joint Commission, quality metrics, opioid reduction initiatives and guidelines
Interviewed range of external stakeholders (e.g., Hospital CEO, IDN Chief Quality Director) and numerous internal experts
Conducted secondary research and reviewed prior internal assessments and brand plans
We uncovered a number of opportunities to strengthen access which our client had not previously considered
Opus synthesized recommendations around value proposition, quality metrics, formulary positioning and overall targeting. The work was well-received and client subsequently approached for an additional project